Online multidisciplinary discussion on interstitial lung disease: Using new technologies to connect general hospitals to expert units

This is a preview and has not been published.

Online multidisciplinary discussion on interstitial lung disease: Using new technologies to connect general hospitals to expert units

Authors

  • Joel Francesqui IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Pulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain https://orcid.org/0000-0001-7106-3218
  • Mariana Benegas 3Interstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG); Radiology Department, Hospital Clínic, Barcelona, Spain
  • Elena Laserna Pulmonology Department, Hospital de Mollet, Barcelona, Spain
  • Leticia Valera Pulmonology Department, Hospital de Mollet, Barcelona, Spain
  • Sandra Cuerpo Pulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain
  • Fernanda Hernández-González Pulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain; Interstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG)
  • Mario Serrano Pulmonology Department, Hospital de Mollet, Barcelona, Spain
  • Marcelo Sánchez Interstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG); Radiology Department, Hospital Clínic, Barcelona, Spain
  • Jacobo Sellares Pulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain; Interstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG); Centro de Investigación Biomédica en Red Enfermedades Respiratorias https://orcid.org/0000-0001-6047-1670

Keywords:

multidisciplinary discussion , Interstitial lung disease, online meeting, virtual meeting

Abstract

.

References

1. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48. doi:10.1164/rccm.201308-1483ST.

2. Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: A cohort study. Am J Respir Crit Care Med. 2011;184(7):842–7. doi:10.1164/rccm.201104-0668OC.

3. Oldham JM, Noth I. Idiopathic pulmonary fibrosis: Early detection and referral. Respir Med. 2014;108(6):819–29. doi:10.1016/j.rmed.2014.03.008.

4. Castillo D, Walsh S, Hansell DM, et al. Validation of multidisciplinary diagnosis in IPF. Lancet Respir Med. 2018;6(2):88–9. doi:10.1016/S2213-2600(18)30023-7.

5. Cottin V, Castillo D, Poletti V, Kreuter M, Corte TJ, Spagnolo P. Should patients with interstitial lung disease be seen by experts? Chest. 2018;154(3):713–4. doi:10.1016/j.chest.2018.05.044.

6. Johannson KA, Lethebe BC, Assayag D, et al. Travel distance to subspecialty clinic and outcomes in patients with fibrotic interstitial lung disease. Ann Am Thorac Soc. 2022;19(1):20–7. doi:10.1513/AnnalsATS.202102-216OC.

7. Salonen J, Nurmi H, Hodgson U, et al. Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings. Eur Clin Respir J. 2023;10(1):2190210. doi:10.1080/20018525.2023.2190210.

8. Mackintosh JA, Glenn L, Barnes H, et al. Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology. 2021;26(6):612–5. doi:10.1111/resp.14062.

Downloads

How to Cite

1.
Francesqui J, Benegas M, Laserna E, Valera L, Cuerpo S, Hernández-González F, et al. Online multidisciplinary discussion on interstitial lung disease: Using new technologies to connect general hospitals to expert units. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. [cited 2025 Dec. 7];42(4):17105. Available from: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/17105

Issue

Vol. 42 No. 4 (2025)

Section

Letter to Editor
DOI: https://doi.org/10.36141/svdld.v42i4.17105

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

1.
Francesqui J, Benegas M, Laserna E, Valera L, Cuerpo S, Hernández-González F, et al. Online multidisciplinary discussion on interstitial lung disease: Using new technologies to connect general hospitals to expert units. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. [cited 2025 Dec. 7];42(4):17105. Available from: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/17105
Crossref
Scopus
Google Scholar
Europe PMC